Multiplex genome engineering using CRISPR/Cas systems
- PMID: 23287718
- PMCID: PMC3795411
- DOI: 10.1126/science.1231143
Multiplex genome engineering using CRISPR/Cas systems
Abstract
Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.
Figures
Comment in
-
Technology: a CRISPR genome-editing tool.Nat Rev Genet. 2013 Feb;14(2):80. doi: 10.1038/nrg3409. Epub 2013 Jan 16. Nat Rev Genet. 2013. PMID: 23322222 No abstract available.
-
Molecular biology. New tool for genome surgery.Science. 2013 Feb 15;339(6121):768-70. doi: 10.1126/science.1234726. Science. 2013. PMID: 23413345 No abstract available.
-
RNA-guided gene editing.Nat Methods. 2013 Mar;10(3):189. doi: 10.1038/nmeth.2389. Nat Methods. 2013. PMID: 23565557 No abstract available.
-
Titanic clash over CRISPR patents turns ugly.Nature. 2016 Sep 22;537(7621):460-1. doi: 10.1038/537460a. Nature. 2016. PMID: 27652544 No abstract available.
Similar articles
-
Genome editing using Cas9 nickases.Methods Enzymol. 2014;546:161-74. doi: 10.1016/B978-0-12-801185-0.00008-8. Methods Enzymol. 2014. PMID: 25398340
-
RNA-guided human genome engineering via Cas9.Science. 2013 Feb 15;339(6121):823-6. doi: 10.1126/science.1232033. Epub 2013 Jan 3. Science. 2013. PMID: 23287722 Free PMC article.
-
Efficient genome editing in zebrafish using a CRISPR-Cas system.Nat Biotechnol. 2013 Mar;31(3):227-9. doi: 10.1038/nbt.2501. Epub 2013 Jan 29. Nat Biotechnol. 2013. PMID: 23360964 Free PMC article.
-
Application of CRISPR/Cas9 genome editing to the study and treatment of disease.Arch Toxicol. 2015 Jul;89(7):1023-34. doi: 10.1007/s00204-015-1504-y. Epub 2015 Apr 1. Arch Toxicol. 2015. PMID: 25827103 Review.
-
[CRISPR/Cas system for genome editing in pluripotent stem cells].Tsitologiia. 2015;57(1):19-30. Tsitologiia. 2015. PMID: 25872372 Review. Russian.
Cited by 4,403 articles
-
Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes.BMC Biotechnol. 2020 Aug 18;20(1):40. doi: 10.1186/s12896-020-00638-7. BMC Biotechnol. 2020. PMID: 32811500 Free PMC article.
-
Interrogating Cellular Communication in Cancer with Genetically Encoded Imaging Reporters.Radiol Imaging Cancer. 2020 Jul 31;2(4):e190053. doi: 10.1148/rycan.2020190053. Radiol Imaging Cancer. 2020. PMID: 32803164 Free PMC article. Review.
-
Advances in oligonucleotide drug delivery.Nat Rev Drug Discov. 2020 Aug 11:1-22. doi: 10.1038/s41573-020-0075-7. Online ahead of print. Nat Rev Drug Discov. 2020. PMID: 32782413 Free PMC article. Review.
-
CRISPR/Cas12a mediated knock-in of the Polled Celtic variant to produce a polled genotype in dairy cattle.Sci Rep. 2020 Aug 11;10(1):13570. doi: 10.1038/s41598-020-70531-y. Sci Rep. 2020. PMID: 32782385 Free PMC article.
-
CRISPR Taking the Front Seat in Immunotherapy.J Cell Immunol. 2020;2(4):143-148. doi: 10.33696/immunology.2.032. J Cell Immunol. 2020. PMID: 32776020 No abstract available.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Research Materials